0REZ.LSE AddLife AB

Healthcare Commercial Services & Supplies London Exchange
176.01 SEK
Close of Nov 3, 2026
131.63 192.20
Market cap
SEK 4.23B
P/E
30.4x
P/B
-
ROE
8.6%
Dividend yield
0.46%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0REZ.LSE undervalued?

Graham number

The Graham number of AddLife AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AddLife AB fundamental analysis

No fundamental analysis for AddLife AB yet.

AddLife AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytic…

Full company profile